Pathology and Laboratory Medicine

Cancer Pathology and Tumor Biomarkers

Cancer diagnostics is increasingly reliant on precision pathology, which leverages tumor biomarkers for diagnosis, prognosis, and therapy selection. Tumor heterogeneity, biomarker discovery, and immunopathology have become pivotal in guiding oncology decisions. The session will cover predictive and prognostic biomarkers, molecular subtyping, and the role of companion diagnostics in targeted therapies. Emphasis is placed on integrating histopathology, immunohistochemistry, and molecular profiling for comprehensive cancer evaluation. Insights into liquid biopsies, epigenetics, and resistance mechanisms are also included, offering a holistic view of the future of cancer diagnostics.